novo nordisk semaglutide vial withdraws FDA application to expand use of weight loss drug Novo Nordisk's semaglutide shows promise

10.5056/jnm15203 121

Clinical studies have demonstrated that Semaglutide can result in considerable weight reduction, with individuals experiencing an average loss of 10-20% of their total body weight

Because semaglutide medications have been linked to side effects like nausea, vomiting, diarrhea and constipation, streamlining your diet and avoiding the foods highlighted above may help reduce the likelihood of experiencing these potentially chronic side effects

PlexusDx's Precision Peptide Genetic Test ($99 add-on) identifies your genetic predisposition to GLP-1 sensitivity through variants like GLP1R rs6923761, helping your provider personalize your starting dose and escalation schedule to minimize this particular side effect